Inhibition of JMJD6 by 2-Oxoglutarate Mimics

5Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Studies on the inhibition of the human 2-oxoglutarate dependent oxygenase JMJD6, which is a cancer target, by 2-oxoglutarate mimics / competitors, including human drugs, drug candidates, and metabolites relevant to cancer are described. JMJD6 assays employed NMR to monitor inhibitor binding and use of mass spectrometry to monitor JMJD6-catalysed lysine hydroxylation. Notably, some clinically applied prolyl hydroxylase inhibitors also inhibit JMJD6. The results will help enable the development of inhibitors selective for human oxygenases, including JMJD6.

Cite

CITATION STYLE

APA

Islam, M. S., Thinnes, C. C., Holt-Martyn, J. P., Chowdhury, R., McDonough, M. A., & Schofield, C. J. (2022). Inhibition of JMJD6 by 2-Oxoglutarate Mimics. ChemMedChem, 17(1). https://doi.org/10.1002/cmdc.202100398

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free